Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Introduction
  • ER to Golgi transport by COPII
  • Expansion of COPII paralogs in mammals
  • Specificity of COPII paralogs
  • Specificity of cargo receptors
  • Concluding remarks
  • Acknowledgments
  • Footnotes
  • References
  • Version history
Article has an altmetric score of 13

See more details

Posted by 22 X users
On 1 Facebook pages
40 readers on Mendeley
  • Article usage
  • Citations to this article (17)

Advertisement

Review Series Open Access | 10.1172/JCI163838

Cargo selection in endoplasmic reticulum–to–Golgi transport and relevant diseases

Vi T. Tang1,2 and David Ginsburg2,3,4,5,6

1Department of Molecular and Integrative Physiology,

2Life Sciences Institute,

3Department of Internal Medicine,

4Department of Human Genetics,

5Department of Pediatrics and Communicable Diseases, and

6Howard Hughes Medical Institute, University of Michigan, Ann Arbor, Michigan, USA.

Address correspondence to: David Ginsburg, Mary Sue Coleman Hall, Room 5028, Life Sciences Institute, 210 Washtenaw Avenue, Ann Arbor, Michigan 48109-2216, USA. Phone: 734.647.4808; Email: ginsburg@umich.edu.

Find articles by Tang, V. in: JCI | PubMed | Google Scholar |

1Department of Molecular and Integrative Physiology,

2Life Sciences Institute,

3Department of Internal Medicine,

4Department of Human Genetics,

5Department of Pediatrics and Communicable Diseases, and

6Howard Hughes Medical Institute, University of Michigan, Ann Arbor, Michigan, USA.

Address correspondence to: David Ginsburg, Mary Sue Coleman Hall, Room 5028, Life Sciences Institute, 210 Washtenaw Avenue, Ann Arbor, Michigan 48109-2216, USA. Phone: 734.647.4808; Email: ginsburg@umich.edu.

Find articles by Ginsburg, D. in: JCI | PubMed | Google Scholar |

Published January 3, 2023 - More info

Published in Volume 133, Issue 1 on January 3, 2023
J Clin Invest. 2023;133(1):e163838. https://doi.org/10.1172/JCI163838.
© 2023 Tang1 et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published January 3, 2023 - Version history
View PDF
Abstract

Most proteins destined for the extracellular space or various intracellular compartments must traverse the intracellular secretory pathway. The first step is the recruitment and transport of cargoes from the endoplasmic reticulum (ER) lumen to the Golgi apparatus by coat protein complex II (COPII), consisting of five core proteins. Additional ER transmembrane proteins that aid cargo recruitment are referred to as cargo receptors. Gene duplication events have resulted in multiple COPII paralogs present in the mammalian genome. Here, we review the functions of each COPII protein, human disorders associated with each paralog, and evidence for functional conservation between paralogs. We also provide a summary of current knowledge regarding two prototypical cargo receptors in mammals, LMAN1 and SURF4, and their roles in human health and disease.

Introduction

Cells secrete proteins into the extracellular environment for multiple purposes, including intercellular communication, defense, and modulation of the external environment. In eukaryotes, the majority of secreted proteins must transit through a series of membrane-bound organelles before arriving at the plasma membrane for release into the extracellular environment (1–3). This pathway is also shared by many proteins destined for the cell surface and various intracellular organelles, such as endosomes and lysosomes (2, 3). Proteins enter the intracellular secretory pathway at the endoplasmic reticulum (ER), where they are cotranslationally embedded into the ER membrane or deposited into the ER lumen (4, 5). Properly folded proteins are then transported from the ER to the Golgi apparatus for further processing and sorting before reaching their final extracellular or intracellular destinations (6, 7). A few proteins have been shown to exit the cell via an ER/Golgi–independent process referred to as unconventional protein secretion (8–11). This Review will focus on the early phase of conventional protein secretion, in which proteins are transported from the ER to the Golgi in a process mediated by coat protein complex II (COPII). Genetic disorders associated with deficiency in protein components of COPII will also be described.

ER to Golgi transport by COPII

COPII composition. The components of the COPII coat were first identified through a genetic screen by Randy Schekman and colleagues in 1980 for Saccharomyces cerevisiae mutants that were defective in protein secretion, designated “sec” mutants (12). The core COPII components in S. cerevisiae are Sar1p, Sec23p, Sec24p, Sec13p, and Sec31p (13). The corresponding vertebrate proteins are referred to as SAR1, SEC23, SEC24, SEC13, and SEC31. SAR1 is a small GTPase that recruits other coat proteins to the ER membrane. SEC23 and SEC24 form an inner coat complex that is proximal to the ER membrane. SEC13 and SEC31 form the outer coat complex (Figure 1).

COPII coat assembly on the ER membrane.Figure 1

COPII coat assembly on the ER membrane. SEC12 recruits GDP-bound SAR1 to ER exit sites (ERESs) and acts as a guanine nucleotide exchange factor for SAR1. GTP-bound SAR1 inserts its hydrophobic N-terminus into the ER membrane and recruits SEC23-SEC24 heterodimers to the ER exit site via direct interaction with SEC23. SEC24 mediates cargo recruitment via direct physical interaction with transmembrane proteins through their cytoplasmic tails or with soluble cargoes via cargo receptors. SEC23 also functions as the GTPase-activating protein for SAR1 and stimulates SAR1 GTP hydrolysis. Finally, SEC13-SEC31 heterotetramers are recruited as the outer coat to complete the coat assembly process.

Coat assembly. COPII coat assembly begins in the membrane of the smooth ER (lacking ribosomes) where the localization of SEC12 defines the ER exit site (ERES). SEC12 is a type II ER transmembrane protein that functions as a guanine nucleotide exchange factor (GEF) for SAR1 while also recruiting SAR1 to the ER membrane (14, 15). GTP-bound SAR1 inserts its hydrophobic N-terminus into the ER membrane and recruits SEC23-SEC24 heterodimers to the ERES by directly interacting with SEC23 (16, 17). SEC23 stimulates SAR1 GTPase hydrolysis, thereby functioning as the GTPase-activating protein (GAP) for SAR1, while SEC24 mediates cargo recruitment and concentration in the ER lumen (18). Finally, SEC13 and SEC31 are recruited as an outer coat to complete the coat assembly (19) (Figure 1).

Bulk flow and concentrative transport. Bulk flow is the default secretory pathway in which proteins in the ER lumen can freely and passively leave the ER (20, 21). However, early immunoelectron microscopy and in vitro COPII reconstitution studies demonstrated that some secretory cargoes are selectively concentrated into COPII vesicles/tubules (22–25). Active cargo concentration implies interaction between COPII subunits on the cytoplasmic face of the ER membrane and secretory proteins within the ER lumen. While some transmembrane proteins can directly interact with SEC23/SEC24 in the COPII coat (26–28), other transmembrane and soluble cargoes (proteins without a transmembrane domain that are entirely constrained within the ER lumen) achieve physical interaction with the COPII coat via transmembrane cargo receptors (23) (Figure 1). Several transmembrane cargo receptors and adaptors have been identified in yeast and mammals, including LMAN1, SURF4, lectins such as VIP36, and p24 proteins (29), though it is unclear whether all or most secretory proteins require a cargo receptor for efficient secretion.

Transport from the ER to the Golgi. There are several models for how proteins are transported from one cellular compartment to another (30). From the early 1960s, two distinct models for the identity of transport carriers between the ER and the Golgi have been proposed: discrete vesicles (31) and continuous tubules/tunnels (32, 33). The foundation for the understanding of COPII-mediated ER to Golgi transport over the next few decades relied largely on the vesicular model, in which, following cargo recruitment, the outer coat (SEC13-SEC31) promotes ER membrane fission to generate discrete COPII vesicles 60–90 nm in size (34–37). These vesicles transport secretory proteins, along with the COPII coat proteins, to the ER-Golgi intermediate compartment (ERGIC) or the Golgi, where the vesicles fuse with the Golgi membrane, releasing their secretory cargo into the cis-Golgi network. The ERGIC is a stable membrane compartment between the rough ER and the Golgi that acts as the first post-ER sorting station for anterograde (to the Golgi) and retrograde (back to the ER) trafficking (38). Challenges to this model include the discovery of COPII-free transport carriers (39) and explaining the mechanism for transport of large cargoes such as procollagen (40) or prechylomicrons (41) whose diameters exceed the typical size of COPII vesicles. Recent studies using super-resolution imaging techniques on intact mammalian cells have visualized an interwoven ER network (42), suggesting that COPII coat proteins may remain on the ER membrane and function as a gatekeeper, restricting entry of secretory proteins into tubules rather than acting as an escort accompanying these proteins to the Golgi (43, 44) (Figure 2).

ER to Golgi transport of secreted proteins.Figure 2

ER to Golgi transport of secreted proteins. Secretory proteins in the ER lumen are recruited into the COPII vesicle/tubule by COPII coat proteins. In the vesicular transport model, the vesicle buds from the ER and travels to the ERGIC/cis-Golgi network with COPII coat proteins accompanying the vesicle. In the tubular transport model, cargo proteins are transported in a continuous interwoven tubular network instead of discrete vesicles. COPII proteins remain on the ER membrane and function as a gatekeeper restricting entry of secretory proteins into tubules.

Expansion of COPII paralogs in mammals

COPII proteins are highly conserved throughout eukaryotic evolution, and SEC23 and SEC24 orthologs have also been identified in Asgard, an archaea superphylum that is considered the closest prokaryotic relative of eukaryotes (45, 46). Comparative genomic studies identify at least one paralog for each of the five core COPII proteins (SAR1, SEC23, SEC24, SEC13, and SEC31) in every eukaryote genome analyzed, suggesting that all five are present in the last eukaryotic common ancestor (47, 48). Gene duplications have led to expansions of all five COPII proteins in multicellular plants and all but SEC13 in vertebrates (Table 1). Gene duplications are common evolutionary events. Typically, one duplicated copy accumulates loss-of-function mutations, becoming a pseudogene, and is eventually lost from the genome. Occasionally, both gene copies are conserved through neofunctionalization, in which one paralog acquires a new function, or subfunctionalization, in which the paralogs divide the functions of the ancestral gene. In the latter case, the division of functions can occur at the protein level or at the transcription level (49). A widely proposed explanation for the existence and conservation of multiple COPII paralogs in higher organisms is that each paralog has evolved unique functions to accommodate a more diverse secretome across different cell types. However, recent studies demonstrate that some paralogs have largely similar functions and can thus compensate for the loss of their partner paralog. Below, we will review and compare the reported human and mouse phenotypes associated with genetic deficiency for each COPII component as well as evidence for unique and/or redundant functions between paralogs.

Table 1

COPII paralogs in mammals and associated human disease or mouse phenotype

Specificity of COPII paralogs

SAR1. The first COPII protein recruited by SEC12 to the ERES is SAR1, which, in turn, recruits other COPII subunits to the ER membrane. Regulation of SAR1 GTPase kinetics by SEC23 and SEC31 is thought to be important for concentration of large cargo proteins (50). Most invertebrate genomes contain a single SAR1 gene, whereas most vertebrates, including mammals, contain two paralogs: SAR1A and SAR1B. The human SAR1A and SAR1B paralogs differ at only 20 of 198 amino acid residues. Though the average degree of amino acid sequence identity for orthologous proteins between the human and mouse genomes is about 85%, each of the human and mouse SAR1 ortholog pairs exhibits about 98% sequence identity, differing in only three amino acids for SAR1A and two amino acids for SAR1B.

Despite this high degree of similarity between the two SAR1 paralogs, human genetic data suggest distinct functions for SAR1A and SAR1B. Although both SAR1 paralogs are highly expressed in the intestine, only mutations in SAR1B have been linked to the rare autosomal recessive disorder chylomicron retention disease (CMRD, or Anderson’s disease) (51–53), and no human disorder has yet been associated with mutations in SAR1A. The approximately 1.5-fold increase in the expression of SAR1A in CMRD patients does not compensate for the loss of SAR1B (53). CMRD is characterized by failure to thrive and chronic diarrhea in infants due to malabsorption of dietary lipids and fat-soluble vitamins (54, 55). In CMRD patients, secretion of chylomicrons from the enterocytes is inhibited because of an inability to transport chylomicrons from the ER and/or abnormal fusion of prechylomicron transport vesicles to the Golgi — processes for which SAR1B appears to be required (56).

To explore the question of redundant/unique function between SAR1 paralogs at the molecular level, Melville et al. (57) identified three clusters of at least three amino acid sequence differences between SAR1A and SAR1B. Two of these clusters are highly conserved among mammals, reptiles, and birds. One cluster is adjacent to the GTP-binding pocket, and the other is on an α-helix near the known binding site of SEC31 on SEC23, which might influence SAR1 interaction with the SEC23-SEC31 complex. Further analyses demonstrated a faster GTPase exchange rate for SAR1A than for SAR1B, with a swap of the amino acid cluster adjacent to the GTP-binding pocket reversing this difference between the two paralogs. In contrast, SAR1B binds more strongly to SEC23 than does SAR1A, and swapping the α-helix amino acid cluster reverses SEC23 affinity. These data indicate that SAR1A and SAR1B have some distinct biochemical properties at the molecular level.

However, limited in vitro data suggest some degree of functional overlap for these SAR1 paralogs. Inactivation of SAR1B in human Caco-2/15 cells, a chylomicron-secreting cell line, results in decreased chylomicron secretion, disrupted lipid homeostasis, and increased oxidative stress (58, 59). SAR1A-null Caco-2/15 cells exhibit a similar but less dramatic phenotype (59). Combined deletion of SAR1A and SAR1B was required to recapitulate the more severe phenotype observed in patients with CMRD. This discrepancy between in vivo and in vitro could potentially be explained by relative expression levels of SAR1A and SAR1B. SAR1B is expressed at approximately 3-fold higher levels than SAR1A in human intestine (53), while SAR1A is expressed at slightly higher levels than SAR1B in Caco-2/15 cells, with a further approximately 1.3-fold increase in SAR1A expression following SAR1B deletion (58). In mice, loss of expression from a single Sar1b allele is sufficient to recapitulate the reduced chylomicron secretion phenotype seen in humans, with homozygous Sar1b deletion in mice resulting in late-gestation lethality (60). Taken together, these data suggest at least some degree of functional overlap between SAR1A and SAR1B, with the total level of SAR1 expression providing an important determinant for CMRD manifestations.

SEC23. SEC23 is a cytosolic protein that forms a heterodimer with SEC24. The SEC23-SEC24 complex is recruited to the ER membrane by SAR1 and, together with SAR1, forms the inner COPII coat, which recruits cargo proteins from the ER lumen (61, 62). Though invertebrate genomes generally encode a single SEC23 gene, most vertebrate genomes, including mammal genomes, encode two SEC23 paralogs, SEC23A and SEC23B (48). The SEC23 gene duplication is estimated to have occurred about 615 million years ago. The two mammalian SEC23 paralogs share about 85% sequence identity at the amino acid level, whereas the human and mouse SEC23A and SEC23B orthologs are about 98% and about 97% identical at the protein level, respectively (63).

Human genetic data again suggest that the SEC23 paralogs have evolved divergent functions. Despite ubiquitous expression of both SEC23A and SEC23B, loss-of-function mutations in each paralog lead to different disorders affecting distinct cell types. Mutations in human SEC23A result in defective collagen secretion leading to the autosomal recessive condition cranio-lenticulo-sutural dysplasia (CLSD), characterized by abnormal cranial fontanel closures, facial dysmorphisms, skeletal abnormalities, and sutural cataracts (64, 65). In contrast, mutations in SEC23B result in congenital dyserythropoietic anemia type II (CDAII), an autosomal recessive disorder characterized by anemia and increased numbers of bi/multinucleated red blood cell precursors in the bone marrow (66, 67). Additionally, expression of human SEC23A and not SEC23B has been shown to rescue Sec23p-null yeast, which is also consistent with unique functions for the two mammalian SEC23 paralogs (68).

Initial results from mouse models also suggested distinct, though potentially partially overlapping, functions for SEC23A and SEC23B. Sec23a-null mice exhibit mid-embryonic lethality associated with defective extraembryonic membrane development and neural tube closure in the midbrain, likely due to impaired secretion of multiple collagen types (69), and consistent with the collagen secretion defect observed in humans with CLSD. However, in contrast to human SEC23B deficiency, SEC23B-deficient mice exhibit an entirely normal red blood cell phenotype (70, 71), instead demonstrating perinatal lethality due to degeneration of the pancreas (70, 72). There is also no evidence for altered collagen secretion in Sec23b-null mice (70). Notably, complete loss of one SEC23 paralog in combination with haploinsufficiency of the remaining paralog results in embryonic death at an earlier developmental time (69), suggesting some degree of overlapping functions between the paralogs.

Though it was previously demonstrated that only human SEC23A can rescue Sec23p deficiency in yeast, a more recent study shows that murine and human SEC23A and SEC23B are each individually sufficient to complement the loss of Sec23p in yeast, and delivery of a sec23a transgene rescues the lethality of Sec23b deficiency in zebrafish (63). Additionally, substitution of the SEC23A coding sequence for that of SEC23B at the endogenous Sec23b locus fully rescued the perinatal lethal pancreatic degeneration seen in SEC23B-deficient mice, with no apparent abnormalities in these adult animals expressing only SEC23A sequences, but under the regulatory control of both the endogenous Sec23a and Sec23b genes (63). Similarly, SEC23A has been demonstrated to overlap in functions with SEC23B in human erythroid cells, with increased SEC23A expression being sufficient to rescue the erythroid differentiation defect in SEC23B-deficient cells (73). Taken together, these data demonstrate that the two mammalian SEC23 paralogs exhibit highly overlapping and potentially identical functions, with the discordant phenotypes observed between SEC23A and SEC23B deficiencies, and between humans and mice, resulting primarily from evolutionary differences in tissue-specific gene expression programs. Consistent with this hypothesis, murine Sec23a gene expression has been shown to be maintained throughout erythropoiesis, in contrast to human SEC23A expression, which declines rapidly upon induction of terminal erythroid differentiation (74), potentially explaining the absence of a red blood cell phenotype in mice with hematopoietic deficiency of SEC23B (71). Indeed, inactivation of all four Sec23 alleles in erythroid cells is required to reproduce the CDAII phenotype in mice (73). While subtle differences in biochemical properties between the SEC23 paralogs (as between the SAR1 paralogs) cannot be excluded, these data suggest that mammalian SEC23A and SEC23B are largely functionally interchangeable.

SEC24. SEC24 is the primary COPII component responsible for cargo selection via either direct interaction with an ER exit signal on the cytoplasmic domain of the cargo protein itself (in the case of transmembrane proteins) or an indirect interaction mediated through a cargo receptor (for soluble cargoes restricted to the ER lumen) (26). SEC24 has also been implicated in autophagy of the ER (ER-phagy), with SEC24A/B involved in bulk ER-phagy (75), whereas SEC24C is required for selective ER-phagy (76). We refer readers to other reviews for a more detailed discussion of ER-phagy and crosstalk between the secretory and autophagy pathways (77, 78).

Several cargo binding sites on SEC24 have been mapped (27). SEC24 is the only COPII component encoded by more than one paralogous gene in yeast (Sec24, Lst1, and Iss1). Yeast Sec24p shares 55% and 23% protein sequence identity with Iss1p and Lst1p, respectively, with overexpression of Iss1p, but not Lst1p, sufficient to rescue Sec24p deficiency (79–81). Mammalian genomes encode four SEC24 paralogs, SEC24A–SEC24D, with the SEC24A and SEC24B subgroup more similar to yeast Sec24p and Iss1p, and the SEC24C and SEC24D subgroup more similar to yeast Lst1p (82, 83). Analysis of available eukaryotic SEC24 sequences suggests the presence of at least three SEC24 paralogs in the last common eukaryotic ancestor (48). Human SEC24 paralogs share about 50% sequence identity within and about 25% sequence identity across subgroups at the amino acid level. All SEC24 paralogs contain a highly conserved C-terminal region and a hypervariable N-terminal segment (84). Given the role of SEC24 in cargo recruitment, the expansion of COPII paralogs is thought to have been driven to accommodate a greater diversity of secretory cargoes in mammals. Current evidence suggests that SEC24 paralogs within the same subgroup (SEC24A/B versus SEC24C/D) may exhibit largely but not entirely overlapping function, with larger differences in cargo-sorting signal affinity between the two subgroups (85–88).

No human disorders have been associated with mutations in SEC24A or SEC24C. Compound heterozygosity for loss-of-function mutations in SEC24D has been reported to result in a syndromic form of osteogenesis imperfecta (89). Though heterozygous SEC24B missense variants were reported in 4 of 163 cases of neural tube defects (NTDs) in one study (90), these and other missense variants are present in unaffected individuals in the Genome Aggregation Database (gnomAD) (91), arguing against a significant association of heterozygous SEC24B mutations with NTDs. In contrast, a wide range of phenotypes have been reported in mice genetically engineered to be deficient in each of the four SEC24 paralogs. SEC24A-deficient mice demonstrate normal development and survival with the only identifiable phenotype being moderate hypocholesterolemia due to impaired secretion of PCSK9, a plasma protein that negatively regulates low-density lipoprotein (LDL) receptor abundance and, thereby, LDL clearance from circulation (92). SEC24B-deficient mice exhibit late embryonic lethality at approximately E18.5 due to a neural tube closure defect, likely resulting from decreased trafficking of VANGL2, a planar-cell polarity protein (93). Notably, no NTD phenotype was observed in heterozygous Sec24b+/– mice, further arguing against an association between heterozygous mutations in human SEC24B and NTDs. Ubiquitous loss of murine SEC24C results in early embryonic lethality at approximately E7.5 due to abnormal gastrulation and ectoderm development (94), while mice with SEC24C deficiency restricted to neural progenitors demonstrate perinatal lethality and microcephaly due to widespread cell death (95). Lastly, absence of SEC24D results in early embryonic death at or before the eight-cell stage (96). A recent proteomic study using an in vitro vesicle reconstitution system demonstrated that SEC24C and SEC24D preferentially interact with ERGIC1 whereas SEC24A favors CNIH4 (97), a proposed cargo receptor for G protein–coupled receptors (98). Several other cargo-specific preferences for each SEC24 paralog have also been reported, including preference of the cargo PCSK9 for SEC24A/B (92); of VANGL2 for SEC24B (93); of SERT (99), SLC6A14 (100), and autotaxin (101) for SEC24C; and of GABA transporter 1 (GAT1) (102) for SEC24D. The glycine transporter (GLYT1) has also been demonstrated to physically interact with SEC24D, though it is unclear whether this interaction is exclusive to SEC24D, as interactions with the other SEC24 paralogs were not tested in this study (103).

In contrast to this evidence for cargo specificity, other studies suggest significant overlap in cargo repertoire for SEC24 paralogs, especially between those within the same subgroup. The vesicular stomatitis virus G glycoprotein (VSV-G) has been reported to interact strongly with mammalian SEC24A/B but not SEC24C/D, whereas syntaxin 5 and membrin are specifically packaged by mammalian SEC24C/D (84). Similarly, in Sec24a-null mice, inactivation of an additional Sec24b allele results in a further approximately 25% reduction in plasma cholesterol, consistent with partial overlap in function between murine SEC24A and SEC24B (92). In contrast, the human recycling transmembrane protein p24-p23, which acts as a cargo receptor for GPI-anchored CD59, prefers SEC24C/D for ER export (104). Lastly, replacement of the majority of the Sec24c coding sequence with Sec24d at the endogenous Sec24c locus partially rescues the embryonic lethal Sec24c-null phenotype, again suggesting significant functional overlap between SEC24C and SEC24D (87). Taken together, these data demonstrate partial functional overlap between SEC24 paralogs within the same subgroup and divergence between the two subgroups.

SEC31. Heterotetramers of SEC31 and SEC13 form the outer COPII coat (105–107). The SEC13-SEC31 complex mediates membrane deformation. SEC31 also directly interacts with SEC23 to stimulate its GTPase-activating protein (GAP) activity, thereby triggering SAR1 GTP hydrolysis (108). It has been suggested that SEC31 fine-tunes SEC23 GAP kinetics to accommodate large cargoes such as collagen (109, 110). Indeed, downregulation of SEC31 as a result of SEC13 depletion in HeLa cells leads to impaired secretion of collagen but not of the temperature-sensitive VSV-G–ts045 glycoprotein (111). VSV-G is a viral protein that is evolutionarily optimized for ER-Golgi export, and experimentation with this protein requires overexpression and culturing of cells at high temperature for a prolonged period. It is unclear whether deletion of SEC31 would produce the same effect for physiologic cargoes. Mammalian genomes encode two paralogs of SEC31 (SEC31A and SEC31B), while yeast contains only a single Sec31 gene. SEC31A is highly expressed in most human tissues, except for the brain, whereas SEC31B is expressed at low levels in most tissues, except for the cerebellum and testis. Human SEC31A shares about 45% sequence identity with SEC31B, and these two paralogs share about 26% and about 19% sequence similarity, respectively, with yeast Sec31p at the amino acid level (112–114). Human SEC31B also appears to be alternatively spliced, producing a C-terminally truncated protein that is about 41% of the full-length SEC31B, though the function of this truncated SEC31B is unclear (114). No human disorder has been associated with mutations in either SEC31 paralog, and mouse models have also not yet been reported.

Though there are currently no published data to assess potential functional overlap among vertebrate SEC31 paralogs, there is some evidence for such overlap in plants. The Arabidopsis genome also encodes two SEC31 paralogs, which share about 59% protein sequence identity with each other and about 25% protein sequence identity with their human SEC31 orthologs. SEC31B-mutant Arabidopsis are infertile because of a defect in pollen development (115), whereas SEC31A-deficient Arabidopsis exhibit normal vegetative and reproductive development. Inactivation of both SEC31A and SEC31B results in lethality due to impaired gametogenesis (116). SEC31B is expressed at about 600-fold higher levels in most plant tissues than SEC31A. However, SEC31B-null transgenic plants in which SEC31A expression is driven by the SEC31B promoter exhibit normal fertility (116), demonstrating significant functional overlap between these two plant paralogs, with their evolutionary conservation likely driven by their divergent gene expression programs.

SEC13. SEC13, together with SEC31, forms the outer COPII coat complex. SEC13 also interacts with several proteins of the nuclear pore complex and shuttles between the nucleus and the cytoplasm (117–119). The single human SEC13 gene shares about 97% and about 46% sequence identity with mouse and yeast SEC13, respectively. Though SEC13 mutations are not associated with any known human disorder, mice with complete loss of SEC13 are not viable. However, mice with low levels of residual SEC13 appear grossly normal, though exhibiting aberrant expression of several genes involved in immune response and inflammation (120). In zebrafish, deletion of sec13 leads to impaired retinal and gut development associated with a procollagen secretion defect (121, 122). Consistent with these observations, depletion of SEC13 in human intestinal epithelial (Caco-2) cells results in aberrant cyst morphogenesis (123).

Specificity of cargo receptors

As previously noted, cargo receptors are ER transmembrane proteins that bridge the interaction between cargoes in the ER lumen and COPII proteins on the cytoplasmic face of the ER. Several cargo receptors have been described in mammals, including LMAN1 (ERGIC53) and SURF4 (124, 125). The following discussion will focus on LMAN1 and SURF4, which have been extensively studied in vitro and in vivo. For a more comprehensive discussion of other putative ER cargo receptors, the reader is referred to ref. 29.

LMAN1. LMAN1 (also known as ERGIC53) is a 53 kDa type I transmembrane protein that was originally identified as a marker for the ERGIC (126). LMAN1 resides primarily in the ER/ERGIC lumen, with a short C-terminal tail of 12 amino acids, including a dilysine diphenylalanine motif (KKFF), extending into the cytoplasm. The FF motif is required for ER export whereas the KK motif is necessary for ER retrieval (127, 128), facilitating LMAN1 cycling between the ER, ERGIC, and cis-Golgi. The LMAN1 luminal segment includes an L-type lectin domain that binds to mannose in a Ca2+-dependent manner (129, 130). LMAN1 was initially suspected to function as a cargo receptor, recruiting secretory proteins in the ER lumen and escorting them to the Golgi, based on its homology to the well-characterized yeast cargo receptor Emp47p (131). The identification of loss-of-function mutation in LMAN1 as the cause of the autosomal recessive human bleeding disorder combined factor V and factor VIII deficiency (F5F8D) (132, 133) identified these two proteins as putative cargoes for LMAN1. F5F8D patients exhibit plasma levels of coagulation factor V (FV) and factor VIII (FVIII) reduced to 5%–30% of normal (134). Further studies identified other potential LMAN1 cargoes, including the lysosomal proteins cathepsin C (CTSC) (135) and cathepsin Z (CTSZ) (136), membrane protein GABA type A receptors (GABAARs) (137), and other secreted proteins including α1-antitrypsin (A1AT) (138), Mac-2–binding protein (Mac-2BP) (139), and matrix metalloproteinase-9 (MMP-9) (140).

Mutations in LMAN1 account for about 70% of cases of F5F8D (141), with the remaining ~30% of cases due to inactivating mutations in MCFD2 (142). Together, mutations in LMAN1 and MCFD2 appear to account for all cases of F5F8D (143). MCFD2 is a 16 kDa soluble EF-hand–containing protein that lacks an ER retrieval motif and is retained in the ER by forming a stable, Ca2+-dependent 1:1 stoichiometry complex with LMAN1 (142, 144). In the absence of LMAN1, MCFD2 is efficiently secreted (145). For efficient ER exit, dimerization of LMAN1 is required (146); however, LMAN1 hexamers have also been observed (147, 148).

The recognition motif for LMAN1/MCDF2-dependent cargoes is unclear, and the LMAN1 cargo repertoire appears to be limited (149). The few known LMAN1/MCFD2 cargoes have been identified by various approaches, including overexpression of an ER-trapped LMAN1 mutant in HeLa cells (CTSC; ref. 135), fluorescent-based protein fragment complementation assays (CTSZ, A1AT, Mac-2BP, and MMP-9; refs. 136, 138–140), and mass spectrometry following coimmunoprecipitation (GABAARs; ref. 137). Most of these putative cargoes are heavily glycosylated, with LMAN1 binding shown to be carbohydrate dependent for CTSC, CTSZ, A1AT, Mac-2BP, and MMP-9 (124, 135, 138–140), though not required for FVIII or GABAARs (137, 144). In the absence of LMAN1, MCFD2 can still bind to FVIII; however, it is unclear whether LMAN1 can independently interact with FVIII in the absence of MCFD2 (144). MCFD2 is required for efficient secretion of FV, FVIII, A1AT, and Mac-2BP (139, 144, 150) but is dispensable for CTSC and CTSZ (145). Dependence of FV, FVIII, and A1AT on LMAN1 has been confirmed in vivo, with Lman1-deficient mice exhibiting reduced plasma levels of FV and FVIII and ER accumulation of A1AT in hepatocytes. However, similar accumulation of CTSC and CTSZ was not observed (151).

SURF4. SURF4 is a 29 kDa protein with five transmembrane domains localizing to the ER and ERGIC (152). Similarly to LMAN1, SURF4 also displays a dilysine ER retrieval motif at its cytoplasm-facing C-terminus, facilitating its retention in the ER (153). Erv29p, the SURF4 ortholog in yeast, is the well-characterized cargo receptor for pro–α-factor, carboxypeptidase Y, and proteinase A (154–156). SURF4 and Erv29p are highly conserved across eukaryotes, with orthologs also identified in Caenorhabditis elegans and Drosophila (157). While Erv29p is dispensable in yeast, SFT-4 (the C. elegans ortholog of SURF4) and SURF4 are required for survival in C. elegans and mice, respectively (158, 159). SURF4 was shown to function in conjunction with LMAN1 to maintain ERGIC and Golgi structural integrity (152) and, based on its cellular localization and sequence homology to Erv29p, was long suspected to function as a cargo receptor in mammalian cells, though putative cargoes have only recently been identified.

No human disorder has been associated with mutations in SURF4. However, genetic polymorphism at the SURF4 gene is strongly associated with reduced plasma lipid levels and reduced cardiovascular risk in human populations (160). As noted above, efficient secretion of PCSK9 is specifically dependent on SEC24A, with their localization to opposite sides of the ER membrane implying a requirement for a specific cargo receptor serving as the physical link (92). A whole-genome CRISPR screen in human embryonic kidney cells (HEK293T) identified SURF4 as this putative PCSK9 cargo receptor (125). A recent report confirmed PCSK9 secretion dependence on both SEC24A and SURF4 in HEK293T and human hepatic (HuH7) cells. In addition, the authors demonstrated that disruption of SEC24A-SURF4 binding by a small molecule, 4-phenylbutyrate, inhibits PCSK9 secretion, further supporting the role for SURF4 as a cargo receptor that bridges PCSK9 and SEC24A (161). SFT-4 was also shown to be essential for the trafficking of the yolk protein VIT-2, a component of C. elegans lipoproteins that share about 22% sequence identity with human apolipoprotein B (APOB); this same group demonstrated that SURF4 also serves as a cargo receptor for APOB in human hepatic HepG2 cells (162). Several other SURF4 cargoes have been identified, including growth hormone, dentin sialophosphoprotein (DSPP), amelogenin (163), erythropoietin (164), pathogenic A1AT polymers (165), sonic hedgehog (166), proinsulin (167), and the lysosomal proteins progranulin and prosaposin (168).

Further analysis of multiple potential SURF4 cargoes across multiple vertebrate species led to the proposal of a highly conserved hydrophobic-proline-hydrophobic tripeptide (ER-ESCAPE) motif downstream of the signal peptide for many putative SURF4 cargoes (163). Deletion of SURF4 in human cells significantly reduced the secretion of some proteins with this ER-ESCAPE motif (163). However, several putative SURF4 cargoes noted above do not carry this ER-ESCAPE motif, suggesting the presence of other recognition motifs that have not yet been identified. Proteomic analysis of conditioned media collected from SURF4-deficient cells revealed several SURF4 clients in HEK293T and HuH7 cells, half of which carry the ER-ESCAPE motif or a Cardin-Weintraub motif, which has also been shown to mediate interaction with SURF4 (161, 166). Interestingly, while replacement of the ER-ESCAPE tripeptide motif with glutamic acids (EEE) significantly impairs secretion of several putative SURF4 cargoes (161, 163), APOB, arguably the most well-studied SURF4 cargo in both in vitro and in vivo models, carries the EEE motif downstream of the signal peptide. Taken together, these data suggest a more complex process governing cargo recognition by SURF4.

The above reports suggest that SURF4 may play a role in the trafficking of a much broader range of secretory cargoes compared with LMAN1. Proteomic analysis of in vitro–reconstituted COPII vesicles are also consistent with this model, with SURF4 deletion resulting in the depletion of many more proteins from reconstituted COPII vesicles compared with LMAN1 deletion (149). A recent study demonstrated that SURF4 traffics ER cargoes into an elongated tubular ERGIC that lacks LMAN1. This tubular ERGIC accelerates ER to Golgi trafficking of SURF4 cargoes, suggesting a distinct SURF4 trafficking route (169).

Concluding remarks

Although the conventional ER-Golgi secretory pathway was first identified over five decades ago, a number of key questions remain unanswered. Are the physical carriers that transport secreted proteins from the ER to the Golgi discrete vesicles, elongated tubules, or continuous tunnels that physically connect the two compartments? Early studies by Schekman and colleagues in yeast established the widely accepted COPII vesicle model. However, recent advances in super-resolution live-cell imaging demonstrate the presence of elongated tubules originating from the ERES, with the COPII proteins appearing to function as gatekeepers at the ERES collar rather than as escorts that travel with cargoes to the Golgi. While superficially conflicting, these models are not mutually exclusive, and multiple different pathways may exist, with the path that each specific protein takes depending on its size, relative abundance in the ER lumen, and requirement for a cargo receptor to facilitate its secretion.

Next, although a diverse set of secretory cargoes are transported from ER to Golgi, it remains unclear how many require a cargo receptor to facilitate this process. The thousands of known secreted proteins and the very limited number of putative cargo receptors identified to date are suggestive of a role for a passive bulk flow mechanism, with only a small subset of secreted proteins requiring interaction with a cargo receptor. Alternatively, multiple additional cargo receptors may remain to be identified. Furthermore, even for the small subset of proteins clearly demonstrated to be dependent on a specific cargo receptor for secretion, deletion of the corresponding cargo receptor does not result in complete blockade of secretion, suggesting the presence of an alternative “backup” cargo receptor(s) or another mechanism for basal protein transport, with the cargo receptor only required for maximal secretion efficiency.

Finally, a better understanding of the functional conservation of COPII paralogs might have translational relevance for human diseases resulting from deficiency of a specific COPII protein paralog, such as CMRD (SAR1B) or CDAII (SEC23B). For COPII paralogs exhibiting extensive or complete functional overlap, therapies that upregulate expression of one paralog could potentially compensate for genetic deficiency of the other (73). In addition, future insights into cargo–cargo receptor interactions and binding motifs could facilitate fine-tuning of secretion for a specific cargo protein. Lastly, optimization of cargo–cargo receptor interactions could potentially be leveraged to improve efficiency of recombinant protein production.

Acknowledgments

We thank P. Abbineni and R. Khoriaty for their thoughtful comments. This work was supported by NIH grant R35HL135793 (to DG), American Heart Association Predoctoral Fellowship 20PRE35210706 (to VTT), and a University of Michigan Rackham Predoctoral Fellowship (to VTT). DG is a Howard Hughes Medical Institute Investigator.

Address correspondence to: David Ginsburg, Mary Sue Coleman Hall, Room 5028, Life Sciences Institute, 210 Washtenaw Avenue, Ann Arbor, Michigan 48109-2216, USA. Phone: 734.647.4808; Email: ginsburg@umich.edu.

Footnotes

Conflict of interest: DG benefits from patent royalties paid by Takeda to Boston Children’s Hospital (for recombinant von Willebrand factor) and to the University of Michigan (for recombinant ADAMTS13).

Copyright: © 2023, Tang et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.

Reference information: J Clin Invest. 2023;133(1):e163838. https://doi.org/10.1172/JCI163838.

References
  1. Jamieson JD, Palade GE. Synthesis, intracellular transport, and discharge of secretory proteins in stimulated pancreatic exocrine cells. J Cell Biol. 1971;50(1):135–158.
    View this article via: CrossRef PubMed Google Scholar
  2. Dallner G, et al. Biogenesis of endoplasmic reticulum membranes. J Cell Biol. 1966;30(1):97–117.
    View this article via: CrossRef Google Scholar
  3. Palade G. Intracellular aspects of the process of protein synthesis. Science. 1975;189(4200):347–358.
    View this article via: CrossRef PubMed Google Scholar
  4. Redman CM, et al. Synthesis and transfer of amylase in pigeon pancreatic microsomes. J Biol Chem. 1966;241(5):1150–1158.
    View this article via: CrossRef Google Scholar
  5. Blobel G, Sabatini DD. Controlled proteolysis of nascent polypeptides in rat liver cell fractions. I. Location of the polypeptides within ribosomes. J Cell Biol. 1970;45(1):130–145.
    View this article via: CrossRef PubMed Google Scholar
  6. Jamieson JD, Palade GE. Intracellular transport of secretory proteins in the pancreatic exocrine cell. I. Role of the peripheral elements of the Golgi complex. J Cell Biol. 1967;34(2):577–596.
    View this article via: CrossRef PubMed Google Scholar
  7. Jamieson JD, Palade GE. Intracellular transport of secretory proteins in the pancreatic exocrine cell. II. Transport to condensing vacuoles and zymogen granules. J Cell Biol. 1967;34(2):597–615.
    View this article via: CrossRef PubMed Google Scholar
  8. Dimou E, Nickel W. Unconventional mechanisms of eukaryotic protein secretion. Curr Biol. 2018;28(8):R406–R410.
    View this article via: CrossRef PubMed Google Scholar
  9. Kim J, et al. Unconventional protein secretion — new insights into the pathogenesis and therapeutic targets of human diseases. J Cell Sci. 2018;131(12):jcs213686.
    View this article via: CrossRef PubMed Google Scholar
  10. Rabouille C. Pathways of unconventional protein secretion. Trends Cell Biol. 2017;27(3):230–240.
    View this article via: CrossRef PubMed Google Scholar
  11. Filaquier A, et al. Roads and hubs of unconventional protein secretion. Curr Opin Cell Biol. 2022;75:102072.
    View this article via: CrossRef PubMed Google Scholar
  12. Novick P, et al. Identification of 23 complementation groups required for post-translational events in the yeast secretory pathway. Cell. 1980;21(1):205–215.
    View this article via: CrossRef PubMed Google Scholar
  13. Barlowe C, et al. COPII: a membrane coat formed by Sec proteins that drive vesicle budding from the endoplasmic reticulum. Cell. 1994;77(6):895–907.
    View this article via: CrossRef PubMed Google Scholar
  14. Barlowe C, et al. Purification and characterization of SAR1p, a small GTP-binding protein required for transport vesicle formation from the endoplasmic reticulum. J Biol Chem. 1993;268(2):873–879.
    View this article via: CrossRef PubMed Google Scholar
  15. Barlowe C, Schekman R. SEC12 encodes a guanine-nucleotide-exchange factor essential for transport vesicle budding from the ER. Nature. 1993;365(6444):347–349.
    View this article via: CrossRef PubMed Google Scholar
  16. Huang M, et al. Crystal structure of Sar1-GDP at 1.7 A resolution and the role of the NH2 terminus in ER export. J Cell Biol. 2001;155(6):937–948.
    View this article via: CrossRef Google Scholar
  17. Bi X, et al. Structure of the Sec23/24-Sar1 pre-budding complex of the COPII vesicle coat. Nature. 2002;419(6904):271–277.
    View this article via: CrossRef Google Scholar
  18. Yoshihisa T, et al. Requirement for a GTPase-activating protein in vesicle budding from the endoplasmic reticulum. Science. 1993;259(5100):1466–1468.
    View this article via: CrossRef PubMed Google Scholar
  19. Lederkremer GZ, et al. Structure of the Sec23p/24p and Sec13p/31p complexes of COPII. Proc Natl Acad Sci U S A. 2001;98(19):10704–10709.
    View this article via: CrossRef PubMed Google Scholar
  20. Wieland FT, et al. The rate of bulk flow from the endoplasmic reticulum to the cell surface. Cell. 1987;50(2):289–300.
    View this article via: CrossRef PubMed Google Scholar
  21. Thor F, et al. Bulk flow revisited: transport of a soluble protein in the secretory pathway. Traffic. 2009;10(12):1819–1830.
    View this article via: CrossRef PubMed Google Scholar
  22. Bendayan M, et al. Quantitative immunocytochemical localization of pancreatic secretory proteins in subcellular compartments of the rat acinar cell. J Histochem Cytochem. 1980;28(2):149–160.
    View this article via: CrossRef PubMed Google Scholar
  23. Kuehn MJ, et al. COPII-cargo interactions direct protein sorting into ER-derived transport vesicles. Nature. 1998;391(6663):187–190.
    View this article via: CrossRef PubMed Google Scholar
  24. Malkus P, et al. Concentrative sorting of secretory cargo proteins into COPII-coated vesicles. J Cell Biol. 2002;159(6):915–921.
    View this article via: CrossRef PubMed Google Scholar
  25. Balch WE, et al. Vesicular stomatitis virus glycoprotein is sorted and concentrated during export from the endoplasmic reticulum. Cell. 1994;76(5):841–852.
    View this article via: CrossRef PubMed Google Scholar
  26. Miller E, et al. Cargo selection into COPII vesicles is driven by the Sec24p subunit. EMBO J. 2002;21(22):6105–6113.
    View this article via: CrossRef PubMed Google Scholar
  27. Miller EA, et al. Multiple cargo binding sites on the COPII subunit Sec24p ensure capture of diverse membrane proteins into transport vesicles. Cell. 2003;114(4):497–509.
    View this article via: CrossRef PubMed Google Scholar
  28. Mossessova E, et al. SNARE selectivity of the COPII coat. Cell. 2003;114(4):483–495.
    View this article via: CrossRef PubMed Google Scholar
  29. Barlowe C, Helenius A. Cargo capture and bulk flow in the early secretory pathway. Annu Rev Cell Dev Biol. 2016;32(1):197–222.
    View this article via: CrossRef PubMed Google Scholar
  30. Mironov AA, Beznoussenko GV. Models of intracellular transport: pros and cons. Front Cell Dev Biol. 2019;7:146.
    View this article via: CrossRef PubMed Google Scholar
  31. Caro LG, Palade GE. Protein synthesis, storage, and discharge in the pancreatic exocrine cell. An autoradiographic study. J Cell Biol. 1964;20:473–495.
    View this article via: CrossRef PubMed Google Scholar
  32. Claude A. Growth and differentiation of cytoplasmic membranes in the course of lipoprotein granule synthesis in the hepatic cell. I. Elaboration of elements of the Golgi complex. J Cell Biol. 1970;47(3):745–766.
    View this article via: CrossRef PubMed Google Scholar
  33. Morre DJ, et al. Golgi apparatus function in membrane transformations and product compartmentalization: studies with cell fractions isolated from rat liver. Adv Cytopharmacol. 1971;1:159–182.
    View this article via: PubMed Google Scholar
  34. Kaiser CA, Schekman R. Distinct sets of SEC genes govern transport vesicle formation and fusion early in the secretory pathway. Cell. 1990;61(4):723–733.
    View this article via: CrossRef PubMed Google Scholar
  35. Barlowe C, et al. COPII: a membrane coat formed by Sec proteins that drive vesicle budding from the endoplasmic reticulum. Cell. 1994;77(6):895–907.
    View this article via: CrossRef PubMed Google Scholar
  36. Bednarek SY, et al. COPI- and COPII-coated vesicles bud directly from the endoplasmic reticulum in yeast. Cell. 1995;83(7):1183–1196.
    View this article via: CrossRef PubMed Google Scholar
  37. Zeuschner D, et al. Immuno-electron tomography of ER exit sites reveals the existence of free COPII-coated transport carriers. Nat Cell Biol. 2006;8(4):377–383.
    View this article via: CrossRef PubMed Google Scholar
  38. Appenzeller-Herzog C, Hauri HP. The ER-Golgi intermediate compartment (ERGIC): in search of its identity and function. J Cell Sci. 2006;119(pt 11):2173–2183.
    View this article via: CrossRef PubMed Google Scholar
  39. Mironov AA, et al. ER-to-Golgi carriers arise through direct en bloc protrusion and multistage maturation of specialized ER exit domains. Dev Cell. 2003;5(4):583–594.
    View this article via: CrossRef PubMed Google Scholar
  40. Bachinger HP, et al. Mouse procollagen IV. Characterization and supramolecular association. J Biol Chem. 1982;257(16):9796–9803.
    View this article via: CrossRef PubMed Google Scholar
  41. Zilversmit DB. Formation and transport of chylomicrons. Fed Proc. 1967;26(6):1599–1605.
    View this article via: PubMed Google Scholar
  42. Weigel AV, et al. ER-to-Golgi protein delivery through an interwoven, tubular network extending from ER. Cell. 2021;184(9):2412–2429.
    View this article via: CrossRef PubMed Google Scholar
  43. Shomron O, et al. COPII collar defines the boundary between ER and ER exit site and does not coat cargo containers. J Cell Biol. 2021;220(6):e201907224.
    View this article via: CrossRef PubMed Google Scholar
  44. Westrate LM, et al. Vesicular and uncoated Rab1-dependent cargo carriers facilitate ER to Golgi transport. J Cell Sci. 2020;133(14):jcs239814.
    View this article via: PubMed Google Scholar
  45. Zaremba-Niedzwiedzka K, et al. Asgard archaea illuminate the origin of eukaryotic cellular complexity. Nature. 2017;541(7637):353–358.
    View this article via: CrossRef PubMed Google Scholar
  46. Eme L, et al. Archaea and the origin of eukaryotes. Nat Rev Microbiol. 2018;16(2):120.
  47. Neumann N, et al. Comparative genomic evidence for a complete nuclear pore complex in the last eukaryotic common ancestor. PLoS One. 2010;5(10):e13241.
    View this article via: CrossRef PubMed Google Scholar
  48. Schlacht A, Dacks JB. Unexpected ancient paralogs and an evolutionary model for the COPII coat complex. Genome Biol Evol. 2015;7(4):1098–1109.
    View this article via: CrossRef PubMed Google Scholar
  49. Innan H, Kondrashov F. The evolution of gene duplications: classifying and distinguishing between models. Nat Rev Genet. 2010;11(2):97–108.
    View this article via: CrossRef PubMed Google Scholar
  50. Saito K, et al. Regulation of the Sar1 GTPase cycle is necessary for large cargo secretion from the endoplasmic reticulum. Front Cell Dev Biol. 2017;5:75.
    View this article via: CrossRef PubMed Google Scholar
  51. Jones B, et al. Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat Genet. 2003;34(1):29–31.
    View this article via: CrossRef PubMed Google Scholar
  52. Charcosset M, et al. Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein. Mol Genet Metab. 2008;93(1):74–84.
    View this article via: CrossRef PubMed Google Scholar
  53. Georges A, et al. Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson’s disease (chylomicron retention disease). Orphanet J Rare Dis. 2011;6:1.
    View this article via: CrossRef PubMed Google Scholar
  54. Anderson CM, et al. Unusual causes of steatorrhoea in infancy and childhood. Med J Aust. 1961;48(2):617–622.
    View this article via: PubMed Google Scholar
  55. Peretti N, et al. Chylomicron retention disease: a long term study of two cohorts. Mol Genet Metab. 2009;97(2):136–142.
    View this article via: CrossRef PubMed Google Scholar
  56. Siddiqi SA, et al. COPII proteins are required for Golgi fusion but not for endoplasmic reticulum budding of the pre-chylomicron transport vesicle. J Cell Sci. 2003;116(pt 2):415–427.
    View this article via: CrossRef PubMed Google Scholar
  57. Melville DB, et al. Small sequence variations between two mammalian paralogs of the small GTPase SAR1 underlie functional differences in coat protein complex II assembly. J Biol Chem. 2020;295(25):8401–8412.
    View this article via: CrossRef PubMed Google Scholar
  58. Sane AT, et al. Understanding chylomicron retention disease through Sar1b GTPase gene disruption: insight from cell culture. Arterioscler Thromb Vasc Biol. 2017;37(12):2243–2251.
    View this article via: CrossRef PubMed Google Scholar
  59. Sane A, et al. SAR1B GTPase is necessary to protect intestinal cells from disorders of lipid homeostasis, oxidative stress, and inflammation. J Lipid Res. 2019;60(10):1755–1764.
    View this article via: CrossRef PubMed Google Scholar
  60. Auclair N, et al. Sar1b mutant mice recapitulate gastrointestinal abnormalities associated with chylomicron retention disease. J Lipid Res. 2021;62:100085.
    View this article via: CrossRef PubMed Google Scholar
  61. Matsuoka K, et al. COPII-coated vesicle formation reconstituted with purified coat proteins and chemically defined liposomes. Cell. 1998;93(2):263–275.
    View this article via: CrossRef PubMed Google Scholar
  62. Lee MC, et al. Sar1p N-terminal helix initiates membrane curvature and completes the fission of a COPII vesicle. Cell. 2005;122(4):605–617.
    View this article via: CrossRef PubMed Google Scholar
  63. Khoriaty R, et al. Functions of the COPII gene paralogs SEC23A and SEC23B are interchangeable in vivo. Proc Natl Acad Sci U S A. 2018;115(33):E7748–E7757.
    View this article via: PubMed Google Scholar
  64. Boyadjiev SA, et al. Cranio-lenticulo-sutural dysplasia is caused by a SEC23A mutation leading to abnormal endoplasmic-reticulum-to-Golgi trafficking. Nat Genet. 2006;38(10):1192–1197.
    View this article via: CrossRef PubMed Google Scholar
  65. Boyadjiev SA, et al. Cranio-lenticulo-sutural dysplasia associated with defects in collagen secretion. Clin Genet. 2011;80(2):169–176.
    View this article via: CrossRef PubMed Google Scholar
  66. Schwarz K, et al. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet. 2009;41(8):936–940.
    View this article via: CrossRef PubMed Google Scholar
  67. Khoriaty R, et al. The COPII pathway and hematologic disease. Blood. 2012;120(1):31–38.
    View this article via: CrossRef PubMed Google Scholar
  68. Paccaud JP, et al. Cloning and functional characterization of mammalian homologues of the COPII component Sec23. Mol Biol Cell. 1996;7(10):1535–1546.
    View this article via: CrossRef PubMed Google Scholar
  69. Zhu M, et al. Neural tube opening and abnormal extraembryonic membrane development in SEC23A deficient mice. Sci Rep. 2015;5:15471.
    View this article via: CrossRef PubMed Google Scholar
  70. Tao J, et al. SEC23B is required for the maintenance of murine professional secretory tissues. Proc Natl Acad Sci U S A. 2012;109(29):E2001–E2009.
    View this article via: PubMed Google Scholar
  71. Khoriaty R, et al. Absence of a red blood cell phenotype in mice with hematopoietic deficiency of SEC23B. Mol Cell Biol. 2014;34(19):3721–3734.
    View this article via: CrossRef PubMed Google Scholar
  72. Khoriaty R, et al. SEC23B is required for pancreatic acinar cell function in adult mice. Mol Biol Cell. 2017;28(15):2146–2154.
    View this article via: CrossRef PubMed Google Scholar
  73. King R, et al. SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II. Sci Adv. 2021;7(48):eabj5293.
    View this article via: CrossRef PubMed Google Scholar
  74. Satchwell TJ, et al. Characteristic phenotypes associated with congenital dyserythropoietic anemia (type II) manifest at different stages of erythropoiesis. Haematologica. 2013;98(11):1788–1796.
    View this article via: CrossRef PubMed Google Scholar
  75. Jeong YT, et al. The ULK1-FBXW5-SEC23B nexus controls autophagy. Elife. 2018;7:e42253.
    View this article via: CrossRef PubMed Google Scholar
  76. Cui Y, et al. A COPII subunit acts with an autophagy receptor to target endoplasmic reticulum for degradation. Science. 2019;365(6448):53–60.
    View this article via: CrossRef PubMed Google Scholar
  77. Anding AL, Baehrecke EH. Cleaning house: selective autophagy of organelles. Dev Cell. 2017;41(1):10–22.
    View this article via: CrossRef PubMed Google Scholar
  78. Davis S, et al. Crosstalk between the secretory and autophagy pathways regulates autophagosome formation. Dev Cell. 2017;41(1):23–32.
    View this article via: CrossRef PubMed Google Scholar
  79. Kurihara T, et al. Sec24p and Iss1p function interchangeably in transport vesicle formation from the endoplasmic reticulum in Saccharomyces cerevisiae. Mol Biol Cell. 2000;11(3):983–998.
    View this article via: CrossRef PubMed Google Scholar
  80. Roberg KJ, et al. LST1 is a SEC24 homologue used for selective export of the plasma membrane ATPase from the endoplasmic reticulum. J Cell Biol. 1999;145(4):659–672.
    View this article via: CrossRef PubMed Google Scholar
  81. Shimoni Y, et al. Lst1p and Sec24p cooperate in sorting of the plasma membrane ATPase into COPII vesicles in Saccharomyces cerevisiae. J Cell Biol. 2000;151(5):973–984.
    View this article via: CrossRef PubMed Google Scholar
  82. Pagano A, et al. Sec24 proteins and sorting at the endoplasmic reticulum. J Biol Chem. 1999;274(12):7833–7840.
    View this article via: CrossRef PubMed Google Scholar
  83. Tang BL, et al. A family of mammalian proteins homologous to yeast Sec24p. Biochem Biophys Res Commun. 1999;258(3):679–684.
    View this article via: CrossRef PubMed Google Scholar
  84. Mancias JD, et al. Structural basis of cargo membrane protein discrimination by the human COPII coat machinery. EMBO J. 2008;27(21):2918–2928.
    View this article via: CrossRef PubMed Google Scholar
  85. Peng R, et al. Evidence for overlapping and distinct functions in protein transport of coat protein Sec24p family members. J Biol Chem. 2000;275(15):11521–11528.
    View this article via: CrossRef PubMed Google Scholar
  86. Wendeler MW, et al. Role of Sec24 isoforms in selective export of membrane proteins from the endoplasmic reticulum. EMBO Rep. 2007;8(3):258–264.
    View this article via: CrossRef PubMed Google Scholar
  87. Adams EJ, et al. Murine SEC24D can substitute functionally for SEC24C during embryonic development. Sci Rep. 2021;11(1):21100.
    View this article via: CrossRef PubMed Google Scholar
  88. Chatterjee S, et al. A systematic review of Sec24 cargo interactome. Traffic. 2021;22(12):412–424.
    View this article via: CrossRef PubMed Google Scholar
  89. Garbes L, et al. Mutations in SEC24D, encoding a component of the COPII machinery, cause a syndromic form of osteogenesis imperfecta. Am J Hum Genet. 2015;96(3):432–439.
    View this article via: CrossRef PubMed Google Scholar
  90. Yang XY, et al. Mutations in the COPII vesicle component gene SEC24B are associated with human neural tube defects. Hum Mutat. 2013;34(8):1094–1101.
    View this article via: CrossRef PubMed Google Scholar
  91. Karczewski KJ, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434–443.
    View this article via: CrossRef Google Scholar
  92. Chen XW, et al. SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion. Elife. 2013;2013(2):1–23.
    View this article via: PubMed Google Scholar
  93. Merte J, et al. Sec24b selectively sorts Vangl2 to regulate planar cell polarity during neural tube closure. Nat Cell Biol. 2010;12(1):41–46.
    View this article via: CrossRef PubMed Google Scholar
  94. Adams EJ, et al. Mammalian COPII coat component SEC24C is required for embryonic development in mice. J Biol Chem. 2014;289(30):20858–20870.
    View this article via: CrossRef PubMed Google Scholar
  95. Wang B, et al. The COPII cargo adapter SEC24C is essential for neuronal homeostasis. J Clin Invest. 2018;128(8):3319–3332.
    View this article via: JCI CrossRef PubMed Google Scholar
  96. Baines AC, et al. Disruption of the Sec24d gene results in early embryonic lethality in the mouse. PLoS One. 2013;8(4):1–10.
    View this article via: PubMed Google Scholar
  97. Adolf F, et al. Proteomic profiling of mammalian COPII and COPI vesicles. Cell Rep. 2019;26(1):250–265.
    View this article via: CrossRef PubMed Google Scholar
  98. Sauvageau E, et al. CNIH4 interacts with newly synthesized GPCR and controls their export from the endoplasmic reticulum. Traffic. 2014;15(4):383–400.
    View this article via: CrossRef PubMed Google Scholar
  99. Sucic S, et al. The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C. J Biol Chem. 2011;286(18):16482–16490.
    View this article via: CrossRef PubMed Google Scholar
  100. Kovalchuk V, et al. Trafficking of the amino acid transporter B(0,+) (SLC6A14) to the plasma membrane involves an exclusive interaction with SEC24C for its exit from the endoplasmic reticulum. Biochim Biophys Acta Mol Cell Res. 2019;1866(2):252–263.
    View this article via: CrossRef PubMed Google Scholar
  101. Lyu L, et al. Selective export of autotaxin from the endoplasmic reticulum. J Biol Chem. 2017;292(17):7011–7022.
    View this article via: CrossRef PubMed Google Scholar
  102. Farhan H, et al. Concentrative export from the endoplasmic reticulum of the gamma-aminobutyric acid transporter 1 requires binding to SEC24D. J Biol Chem. 2007;282(10):7679–7689.
    View this article via: CrossRef PubMed Google Scholar
  103. Fernandez-Sanchez E, et al. Mechanisms of endoplasmic-reticulum export of glycine transporter-1 (GLYT1). Biochem J. 2008;409(3):669–681.
    View this article via: CrossRef PubMed Google Scholar
  104. Bonnon C, et al. Selective export of human GPI-anchored proteins from the endoplasmic reticulum. J Cell Sci. 2010;123(pt 10):1705–1715.
    View this article via: CrossRef PubMed Google Scholar
  105. Salama NR, et al. Sec31 encodes an essential component of the COPII coat required for transport vesicle budding from the endoplasmic reticulum. Mol Biol Cell. 1997;8(2):205–217.
    View this article via: CrossRef PubMed Google Scholar
  106. Gurkan C, Balch WE. Recombinant production in baculovirus-infected insect cells and purification of the mammalian Sec13/Sec31 complex. Methods Enzymol. 2005;404:58–66.
    View this article via: CrossRef PubMed Google Scholar
  107. Stagg SM, et al. Structure of the Sec13/31 COPII coat cage. Nature. 2006;439(7073):234–238.
    View this article via: CrossRef PubMed Google Scholar
  108. Bi X, et al. Insights into COPII coat nucleation from the structure of Sec23.Sar1 complexed with the active fragment of Sec31. Dev Cell. 2007;13(5):635–645.
    View this article via: CrossRef Google Scholar
  109. Fromme JC, Schekman R. COPII-coated vesicles: flexible enough for large cargo? Curr Opin Cell Biol. 2005;17(4):345–352.
    View this article via: CrossRef PubMed Google Scholar
  110. Townley G, and Stephens DJ. Vesicle coating and uncoating: controlling the formation of large COPII-coated carriers. F1000 Biol Rep. 2009;1:65.
    View this article via: PubMed Google Scholar
  111. Townley AK, et al. Efficient coupling of Sec23-Sec24 to Sec13-Sec31 drives COPII-dependent collagen secretion and is essential for normal craniofacial development. J Cell Sci. 2008;121(pt 18):3025–3034.
    View this article via: CrossRef PubMed Google Scholar
  112. Shugrue CA, et al. Identification of the putative mammalian orthologue of Sec31P, a component of the COPII coat. J Cell Sci. 1999;112(pt 24):4547–4556.
    View this article via: CrossRef PubMed Google Scholar
  113. Tang BL, et al. Mammalian homologues of yeast sec31p. An ubiquitously expressed form is localized to endoplasmic reticulum (ER) exit sites and is essential for ER-Golgi transport. J Biol Chem. 2000;275(18):13597–13604.
    View this article via: CrossRef PubMed Google Scholar
  114. Stankewich MC, et al. Human Sec31B: a family of new mammalian orthologues of yeast Sec31p that associate with the COPII coat. J Cell Sci. 2006;119(pt 5):958–969.
    View this article via: CrossRef PubMed Google Scholar
  115. Zhao B, et al. Secretory COPII protein SEC31B is required for pollen wall development. Plant Physiol. 2016;172(3):1625–1642.
    View this article via: CrossRef PubMed Google Scholar
  116. Liu X, et al. COPII genes SEC31A/B are essential for gametogenesis and interchangeable in pollen development in Arabidopsis. Plant J. 2021;105(6):1600–1614.
    View this article via: CrossRef PubMed Google Scholar
  117. Capelson M, et al. Chromatin-bound nuclear pore components regulate gene expression in higher eukaryotes. Cell. 2010;140(3):372–383.
    View this article via: CrossRef PubMed Google Scholar
  118. Siniossoglou S, et al. A novel complex of nucleoporins, which includes Sec13p and a Sec13p homolog, is essential for normal nuclear pores. Cell. 1996;84(2):265–275.
    View this article via: CrossRef PubMed Google Scholar
  119. Enninga J, et al. Sec13 shuttles between the nucleus and the cytoplasm and stably interacts with Nup96 at the nuclear pore complex. Mol Cell Biol. 2003;23(20):7271–7284.
    View this article via: CrossRef PubMed Google Scholar
  120. Moreira TG, et al. Sec13 regulates expression of specific immune factors involved in inflammation in vivo. Sci Rep. 2015;5:17655.
    View this article via: CrossRef PubMed Google Scholar
  121. Niu X, et al. Sec13 safeguards the integrity of the endoplasmic reticulum and organogenesis of the digestive system in zebrafish. Dev Biol. 2012;367(2):197–207.
    View this article via: CrossRef PubMed Google Scholar
  122. Schmidt K, et al. Early stages of retinal development depend on Sec13 function. Biol Open. 2013;2(3):256–266.
    View this article via: CrossRef PubMed Google Scholar
  123. Townley AK, et al. Epithelial organization and cyst lumen expansion require efficient Sec13-Sec31-driven secretion. J Cell Sci. 2012;125(pt 3):673–684.
    View this article via: CrossRef PubMed Google Scholar
  124. Appenzeller C, et al. The lectin ERGIC-53 is a cargo transport receptor for glycoproteins. Nat Cell Biol. 1999;1(6):330–334.
    View this article via: CrossRef PubMed Google Scholar
  125. Emmer BT, et al. The cargo receptor SURF4 promotes the efficient cellular secretion of PCSK9. Elife. 2018;7:1–18.
    View this article via: PubMed Google Scholar
  126. Schindler R, et al. ERGIC-53, a membrane protein of the ER-Golgi intermediate compartment, carries an ER retention motif. Eur J Cell Biol. 1993;61(1):1–9.
    View this article via: PubMed Google Scholar
  127. Itin C, et al. Recycling of the endoplasmic reticulum/Golgi intermediate compartment protein ERGIC-53 in the secretory pathway. Biochem Soc Trans. 1995;23(3):541–544.
    View this article via: CrossRef PubMed Google Scholar
  128. Kappeler F, et al. The recycling of ERGIC-53 in the early secretory pathway. ERGIC-53 carries a cytosolic endoplasmic reticulum-exit determinant interacting with COPII. J Biol Chem. 1997;272(50):31801–31808.
    View this article via: CrossRef PubMed Google Scholar
  129. Velloso LM, et al. Crystal structure of the carbohydrate recognition domain of p58/ERGIC-53, a protein involved in glycoprotein export from the endoplasmic reticulum. J Biol Chem. 2002;277(18):15979–15984.
    View this article via: CrossRef PubMed Google Scholar
  130. Velloso LM, et al. The crystal structure of the carbohydrate-recognition domain of the glycoprotein sorting receptor p58/ERGIC-53 reveals an unpredicted metal-binding site and conformational changes associated with calcium ion binding. J Mol Biol. 2003;334(5):845–851.
    View this article via: CrossRef PubMed Google Scholar
  131. Sato K, Nakano A. Oligomerization of a cargo receptor directs protein sorting into COPII-coated transport vesicles. Mol Biol Cell. 2003;14(7):3055–3063.
    View this article via: CrossRef PubMed Google Scholar
  132. Nichols WC, et al. Linkage of combined factors V and VIII deficiency to chromosome 18q by homozygosity mapping. J Clin Invest. 1997;99(4):596–601.
    View this article via: JCI CrossRef PubMed Google Scholar
  133. Nichols WC, et al. Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell. 1998;93(1):61–70.
    View this article via: CrossRef PubMed Google Scholar
  134. Giddings JC, et al. Immunological studies in combined factor V and factor VIII deficiency. Br J Haematol. 1977;37(2):257–264.
    View this article via: CrossRef PubMed Google Scholar
  135. Vollenweider F, et al. Mistargeting of the lectin ERGIC-53 to the endoplasmic reticulum of HeLa cells impairs the secretion of a lysosomal enzyme. J Cell Biol. 1998;142(2):377–389.
    View this article via: CrossRef PubMed Google Scholar
  136. Nyfeler B, et al. Capturing protein interactions in the secretory pathway of living cells. Proc Natl Acad Sci U S A. 2005;102(18):6350–6355.
    View this article via: CrossRef PubMed Google Scholar
  137. Fu YL, et al. LMAN1 (ERGIC-53) promotes trafficking of neuroreceptors. Biochem Biophys Res Commun. 2019;511(2):356–362.
    View this article via: CrossRef PubMed Google Scholar
  138. Nyfeler B, et al. Identification of ERGIC-53 as an intracellular transport receptor of alpha1-antitrypsin. J Cell Biol. 2008;180(4):705–712.
    View this article via: CrossRef PubMed Google Scholar
  139. Chen Y, et al. Regulation of Mac-2BP secretion is mediated by its N-glycan binding to ERGIC-53. Glycobiology. 2013;23(7):904–916.
    View this article via: CrossRef PubMed Google Scholar
  140. Duellman T, et al. LMAN1 (ERGIC-53) is a potential carrier protein for matrix metalloproteinase-9 glycoprotein secretion. Biochem Biophys Res Commun. 2015;464(3):685–691.
    View this article via: CrossRef PubMed Google Scholar
  141. Nichols WC, et al. ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families. Blood. 1999;93(7):2261–2266.
    View this article via: PubMed Google Scholar
  142. Zhang B, et al. Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat Genet. 2003;34(2):220–225.
    View this article via: CrossRef PubMed Google Scholar
  143. Zhang B, et al. Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2. Blood. 2006;107(5):1903–1907.
    View this article via: CrossRef PubMed Google Scholar
  144. Zhang B, et al. LMAN1 and MCFD2 form a cargo receptor complex and interact with coagulation factor VIII in the early secretory pathway. J Biol Chem. 2005;280(27):25881–25886.
    View this article via: CrossRef PubMed Google Scholar
  145. Nyfeler B, et al. Cargo selectivity of the ERGIC-53/MCFD2 transport receptor complex. Traffic. 2006;7(11):1473–1481.
    View this article via: CrossRef PubMed Google Scholar
  146. Nie C, et al. Dimeric sorting code for concentrative cargo selection by the COPII coat Cell Biology. Proc Natl Acad Sci U S A. 2018;115(14):3155–3162.
  147. Nufer O, et al. ER export of ERGIC-53 is controlled by cooperation of targeting determinants in all three of its domains. J Cell Sci. 2003;116(pt 21):4429–4440.
    View this article via: CrossRef PubMed Google Scholar
  148. Neve EP, et al. Oligomerization and interacellular localization of the glycoprotein receptor ERGIC-53 is independent of disulfide bonds. J Mol Biol. 2005;354(3):556–568.
    View this article via: CrossRef PubMed Google Scholar
  149. Huang Y, et al. An in vitro vesicle formation assay reveals cargo clients and factors that mediate vesicular trafficking. Proc Natl Acad Sci U S A. 2021;118(35):e2101287118.
    View this article via: CrossRef PubMed Google Scholar
  150. Zhang Y, et al. LMAN1-MCFD2 complex is a cargo receptor for the ER-Golgi transport of α1-antitrypsin. Biochem J. 2022;479(7):839–855.
    View this article via: CrossRef PubMed Google Scholar
  151. Zhang B, et al. Mice deficient in LMAN1 exhibit FV and FVIII deficiencies and liver accumulation of α1-antitrypsin. Blood. 2011;118(12):3384–3391.
    View this article via: CrossRef PubMed Google Scholar
  152. Mitrovic S, et al. The cargo receptors Surf4, endoplasmic reticulum-Golgi intermediate compartment (ERGIC)-53, and p25 are required to maintain the architecture of ERGIC and Golgi. Mol Biol Cell. 2008;19(5):1976–1990.
    View this article via: CrossRef PubMed Google Scholar
  153. Reeves JE, Fried M. The surf-4 gene encodes a novel 30 kDa integral membrane protein. Mol Membr Biol. 1995;12(2):201–208.
    View this article via: CrossRef PubMed Google Scholar
  154. Belden WJ, Barlowe C. Role of Erv29p in collecting soluble secretory proteins into ER-derived transport vesicles. Science. 2001;294(5546):1528–1531.
    View this article via: CrossRef PubMed Google Scholar
  155. Caldwell SR, et al. Degradation of endoplasmic reticulum (ER) quality control substrates requires transport between the ER and Golgi. J Biol Chem. 2001;276(26):23296–23303.
    View this article via: CrossRef PubMed Google Scholar
  156. Otte S, Barlowe C. Sorting signals can direct receptor-mediated export of soluble proteins into COPII vesicles. Nat Cell Biol. 2004;6(12):1189–1194.
    View this article via: CrossRef PubMed Google Scholar
  157. Armes N, Fried M. Surfeit locus gene homologs are widely distributed in invertebrate genomes. Mol Cell Biol. 1996;16(10):5591–5596.
    View this article via: CrossRef PubMed Google Scholar
  158. Henricson A, et al. Functional characterization in Caenorhabditis elegans of transmembrane worm-human orthologs. BMC Genomics. 2004;5:85.
    View this article via: CrossRef PubMed Google Scholar
  159. Emmer BT, et al. Murine Surf4 is essential for early embryonic development. PLoS One. 2020;15(1):e0227450.
    View this article via: CrossRef PubMed Google Scholar
  160. Wang X, et al. Receptor-mediated ER export of lipoproteins controls lipid homeostasis in mice and humans. Cell Metab. 2021;33(2):350–366.
    View this article via: CrossRef PubMed Google Scholar
  161. Gomez-Navarro N, et al. Selective inhibition of protein secretion by abrogating receptor-coat interactions during ER export. Proc Natl Acad Sci U S A. 2022;119(31):e2202080119.
    View this article via: CrossRef PubMed Google Scholar
  162. Saegusa K, et al. SFT-4/Surf4 control ER export of soluble cargo proteins and participate in ER exit site organization. J Cell Biol. 2018;217(6):2073–2085.
    View this article via: CrossRef PubMed Google Scholar
  163. Yin Y, et al. Surf4 (Erv29p) binds amino-terminal tripeptide motifs of soluble cargo proteins with different affinities, enabling prioritization of their exit from the endoplasmic reticulum. PLoS Biol. 2018;16(8):e2005140.
    View this article via: CrossRef PubMed Google Scholar
  164. Lin Z, et al. The endoplasmic reticulum cargo receptor SURF4 facilitates efficient erythropoietin secretion. Mol Cell Biol. 2020;40(23):e00180-20.
    View this article via: PubMed Google Scholar
  165. Ordonez A, et al. Cargo receptor-assisted endoplasmic reticulum export of pathogenic α1-antitrypsin polymers. Cell Rep. 2021;35(7):109144.
    View this article via: CrossRef PubMed Google Scholar
  166. Tang X, et al. A SURF4-to-proteoglycan relay mechanism that mediates the sorting and secretion of a tagged variant of sonic hedgehog. Proc Natl Acad Sci U S A. 2022;119(11):e2113991119.
    View this article via: CrossRef PubMed Google Scholar
  167. Saegusa K, et al. Cargo receptor Surf4 regulates endoplasmic reticulum export of proinsulin in pancreatic β-cells. Commun Biol. 2022;5(1):458.
    View this article via: CrossRef PubMed Google Scholar
  168. Devireddy S, Ferguson SM. Efficient progranulin exit from the ER requires its interaction with prosaposin, a Surf4 cargo. J Cell Biol. 2022;221(2):e202104044.
    View this article via: CrossRef PubMed Google Scholar
  169. Yan R, et al. SURF4-induced tubular ERGIC selectively expedites ER-to-Golgi transport. Dev Cell. 2022;57(4):512–525.
    View this article via: CrossRef PubMed Google Scholar
Version history
  • Version 1 (January 3, 2023): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Review Series

Korsmeyer Award 25th Anniversary Collection

  • Hypoxia-inducible factors: cancer progression and clinical translation
    Elizabeth E. Wicks et al.
  • Von Hippel–Lindau disease: insights into oxygen sensing, protein degradation, and cancer
    William G. Kaelin Jr.
  • Targeting ryanodine receptors to treat human diseases
    Andrew R. Marks
  • Cargo selection in endoplasmic reticulum–to–Golgi transport and relevant diseases
    Vi T. Tang et al.
  • Tugs-of-war in science
    Mitchell A. Lazar
  • The 25th Anniversary of the American Society of Clinical Investigation’s Korsmeyer Award
    Benjamin D. Humphreys
  • Entry receptors — the gateway to alphavirus infection
    Ofer Zimmerman et al.
  • Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs
    Jean-Laurent Casanova et al.
  • Lessons learned: from mentored to mentor
    Joseph Heitman

Metrics

Article has an altmetric score of 13
  • Article usage
  • Citations to this article (17)

Go to

  • Top
  • Abstract
  • Introduction
  • ER to Golgi transport by COPII
  • Expansion of COPII paralogs in mammals
  • Specificity of COPII paralogs
  • Specificity of cargo receptors
  • Concluding remarks
  • Acknowledgments
  • Footnotes
  • References
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 22 X users
On 1 Facebook pages
40 readers on Mendeley
See more details